Peter J. Weiler
Chief Financial Officer · Edesa Biotech, Inc.
- 2026
- May 29, 2026
- 1
Summary
Latest filing:
Peter J. Weiler is Chief Financial Officer of Edesa Biotech, Inc. (EDSA). 1 SEC Form 4 filing on record, dated 29 May 2026.
Recent transactions
1The latest SEC Form 4 transaction reported by Peter J. Weiler.
Trading pattern
InsiderAlpha's records for Peter J. Weiler go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter J. Weiler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pardeep Nijhawan - $230K in EDSA purchases and sales in the last 12 months
- Michael J. Brooks - $3K in EDSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter J. Weiler?
Peter J. Weiler is a corporate insider, tracked as Chief Financial Officer of Edesa Biotech, Inc. (EDSA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Peter J. Weiler last file a Form 4?
The only primary Form 4 on record is dated 29 May 2026.